PL2195006T3 - Zastosowanie analogu bifaliny jako przeciwbólowego środka farmaceutycznego - Google Patents
Zastosowanie analogu bifaliny jako przeciwbólowego środka farmaceutycznegoInfo
- Publication number
- PL2195006T3 PL2195006T3 PL08724030.5T PL08724030T PL2195006T3 PL 2195006 T3 PL2195006 T3 PL 2195006T3 PL 08724030 T PL08724030 T PL 08724030T PL 2195006 T3 PL2195006 T3 PL 2195006T3
- Authority
- PL
- Poland
- Prior art keywords
- biphaline
- analog
- pharmaceutical agent
- analgesic pharmaceutical
- analgesic
- Prior art date
Links
- 230000000202 analgesic effect Effects 0.000 title 1
- 239000008177 pharmaceutical agent Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL381925A PL381925A1 (pl) | 2007-03-07 | 2007-03-07 | Zastosowanie peptydu i przeciwbólowy środek farmaceutyczny |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2195006T3 true PL2195006T3 (pl) | 2016-11-30 |
Family
ID=39691054
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL381925A PL381925A1 (pl) | 2007-03-07 | 2007-03-07 | Zastosowanie peptydu i przeciwbólowy środek farmaceutyczny |
| PL08724030.5T PL2195006T3 (pl) | 2007-03-07 | 2008-03-07 | Zastosowanie analogu bifaliny jako przeciwbólowego środka farmaceutycznego |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL381925A PL381925A1 (pl) | 2007-03-07 | 2007-03-07 | Zastosowanie peptydu i przeciwbólowy środek farmaceutyczny |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US9486493B2 (pl) |
| EP (1) | EP2195006B1 (pl) |
| DK (1) | DK2195006T3 (pl) |
| ES (1) | ES2564825T3 (pl) |
| PL (2) | PL381925A1 (pl) |
| WO (1) | WO2008108673A2 (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL381925A1 (pl) | 2007-03-07 | 2008-09-15 | Andrzej W. Lipkowski | Zastosowanie peptydu i przeciwbólowy środek farmaceutyczny |
| EP2384334B8 (en) * | 2008-12-31 | 2013-07-03 | Action For Development Of Resarch SP.Z.O.O. | A method of producing a novel opioid peptide |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5919473A (en) * | 1997-05-12 | 1999-07-06 | Elkhoury; George F. | Methods and devices for delivering opioid analgesics to wounds via a subdermal implant |
| MXPA02003176A (es) * | 1999-10-04 | 2002-09-30 | Shearwater Corp | Neuropeptidos estabilizados por polimero. |
| US6913760B2 (en) * | 2001-08-06 | 2005-07-05 | New England Medical Hospitals, Inc. | Drug delivery composition |
| PL205811B1 (pl) * | 2002-08-13 | 2010-05-31 | Iwona Bonney | Zastosowanie peptydów o działaniu analgetycznym jako substancji czynnej w urządzeniach do podawania leku bezpośrednio do miejsca ich spodziewanego działania przeciwbólowego |
| PL381925A1 (pl) | 2007-03-07 | 2008-09-15 | Andrzej W. Lipkowski | Zastosowanie peptydu i przeciwbólowy środek farmaceutyczny |
-
2007
- 2007-03-07 PL PL381925A patent/PL381925A1/pl unknown
-
2008
- 2008-03-07 DK DK08724030.5T patent/DK2195006T3/en active
- 2008-03-07 US US12/449,944 patent/US9486493B2/en not_active Expired - Fee Related
- 2008-03-07 ES ES08724030.5T patent/ES2564825T3/es active Active
- 2008-03-07 EP EP08724030.5A patent/EP2195006B1/en not_active Not-in-force
- 2008-03-07 WO PCT/PL2008/000020 patent/WO2008108673A2/en not_active Ceased
- 2008-03-07 PL PL08724030.5T patent/PL2195006T3/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20100273715A1 (en) | 2010-10-28 |
| DK2195006T3 (en) | 2016-03-14 |
| ES2564825T3 (es) | 2016-03-29 |
| EP2195006B1 (en) | 2015-12-09 |
| PL381925A1 (pl) | 2008-09-15 |
| WO2008108673A2 (en) | 2008-09-12 |
| EP2195006A2 (en) | 2010-06-16 |
| US9486493B2 (en) | 2016-11-08 |
| WO2008108673A3 (en) | 2008-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2450753B (en) | New Pharmaceutical formulation | |
| ZA200808530B (en) | Pharmaceutical composition for external use | |
| ZA200808531B (en) | Pharmaceutical composition for external use | |
| EP2150109A4 (en) | PHARMACEUTICAL USE OF SUBSTITUTED AMIDES | |
| IL192565A0 (en) | Medicament for topical use | |
| IL203051A (en) | Use of alpha-ketoglutarate for drug preparation | |
| ZA201008584B (en) | A pharmaceutical composition comprising rebamipide | |
| GB2454567B (en) | Anti-malarial pharmaceutical composition | |
| PL2121025T3 (pl) | Sposoby i kompozycje dla dostarczania czynnika terapeutycznego | |
| ZA201103752B (en) | Cycloundecadepsipeptide compounds and use of said compounds as a medicament | |
| PL2341047T3 (pl) | Pochodna cykloheksanowa i jej farmaceutyczne zastosowanie | |
| ZA200908962B (en) | A liquid formulation for administering nicotine | |
| PT2273994E (pt) | Formas de estado sólido de um produto farmacêutico | |
| GB0719248D0 (en) | Compounds and methods for pharmaceutical use | |
| ZA201008115B (en) | A solid pharmaceutical formulation | |
| GB0614586D0 (en) | Pharmaceutical Formulation | |
| SI2409698T1 (sl) | Uporaba indazolmetoksialkanojske kisline za pripravo farmacevtskega sestavka | |
| ZA201104710B (en) | Pharmaceutical dispenser and use thereof | |
| IL213711A (en) | Nano-phenofibrate preparation | |
| EP2431365A4 (en) | AZETIDINE COMPOUND AND ITS MEDICAL USE | |
| PL2195006T3 (pl) | Zastosowanie analogu bifaliny jako przeciwbólowego środka farmaceutycznego | |
| IL202766A0 (en) | Pharmaceutical combination of opioid and prostaglandin compound | |
| AP2788A (en) | Simalikalactone E and use thereof as a medicament | |
| GB0623897D0 (en) | Pharmaceutical composition of memantine | |
| GB0705030D0 (en) | Pharmaceutical formulation |